Tutaj ten tekst w szybkim, automatycznym angielskim:

„Swine flu” vaccine is unsuitable for patients with chronic multi-system illnesses

Pandemrix® represents a substantial health risk because of missing safety records with mass inoculation. Because of the adhesion exemption of the manufacturer by the Federal Government the risk of side effects and/or permanent damage lie by the vaccine in the long run with the patient.

The German Professional Association of the Environmental Medicine (DBU) has concernes about the safety asseverations expressed in the media on the part of the government by the Paul Ehrlich Institute. Serious evidence is available against of the opinion presented by the Federal Government regarding the broad mass inoculation against „the new flu” using „Pandemrix®“of the company GlaxoSmithKline (GSK).

DBU sees here neither the valid medical use of inoculation measures generally nor the necessity for such measures in the so far rather mild process of the swine flu discusses.

Our criticism is directed alone against the Pandemievaccine Pandemrix®.

• Substantial doubts about the effectiveness of the vaccine exist: in the permission phase a vaccine with a portion of virus antigen (5.25 µg), higher around 40%, was tested than the Vaccine delivered now (3.75 µg). There is still no clear consent whether the inoculation uniquely or twice per season is to take place!!!

• Substantial doubts about the safety of the adjuvantierten effect amplifier exist, since this is used for the first time. The vaccine contains 27.4 mg AS03, an emulsion from Polysorbat, Squalen and Tocopherol. Sufficient studies in addition are missing, there in the testing phase as surrogate criterion the structure of anti-body titers were only determined and not any side effects.

• Manufacturers like official places conceal that Squalen is contrary to the oral admission (Squalen is among other things contained as natural substance e.g. in olive oil) with subkutaner or intramuskulärer application a proinflammatorisches immune-activating immunogen.

• Autoimmune diseases can thereby be provoked, already existing be activated. Squalen is brought with the emergence of a Guillan Barré syndrome (GBS) in connection and is considered today as the causes of the Gulf War syndrome (GWS). In animal experiments Squalen released the disease picture of a rheumatoiden Arthritis.

• Squalen from sources of food is built in the organism v.a. into diaphragms. A inoculate-conditioned formation of sqalen-related changes releases chronic inflammations, which explain illnesses such as GWS, in addition, degenerative nerve illnesses such as ms, AS, CIDP and GBS at the diaphragms.

• The distribution of the vaccine in multiple dose ampuls is obsolet. In single dose ampules mercury preservatives as contained Thiomersal would become redundant. Also mercury content in Pandemrix may be a couse of autoimmune diseases out.

• Since the vaccine was tested neither at infants nor at pregnant women (objection of the ethics commission), represents the demand to inoculate straight this particularly endangered subpopulation in the first inoculation phase preferentially an inadmissible field test.

• For environmental patients and immunosupprsed patient (e.g. with AIDS) the vaccine represents a higher risk than the pig flu.

• The manufacturer GlaxoSmithKline (gsk) is to a large extent exempted from the adhesion according to contract with the FRG. In case of an inoculation damage the seed nucleus concerned will thus have to complain instead of approximately gsk against the government and against the German state, a venture as a rule offering no prospects.

• In order to turn out not even in case of adhesion, the inoculation must clear accomplishing physician for the patient up over all risks of the inoculation and the vaccine carefully. It is advisable to accomplish and with a signature of the seed nucleus confirm let this clearing-up in the presence of an aid. The clearing-up should cover also the adhesion-legal characteristics. Also the reference to it that others, lower-risk vaccines in Europe exist, these however because of a wrong decision of the Federal Government for the German population at present not it is available, should not be missing in this clearing-up discussion.

Because of the aforementioned reasons the executive committee of the German professional association of the environmental medical profession publishes the following recommendation:

From general-medical and environmentalmedical considerations DBU advises against urgent execution of the inoculation with Pandemrix®!